These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 21189060

  • 21. Development of self-emulsifying drug delivery systems (SEDDS) for ciprofloxacin with improved mucus permeating properties.
    Zaichik S, Steinbring C, Menzel C, Knabl L, Orth-Höller D, Ellemunter H, Niedermayr K, Bernkop-Schnürch A.
    Int J Pharm; 2018 Aug 25; 547(1-2):282-290. PubMed ID: 29883790
    [Abstract] [Full Text] [Related]

  • 22. Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment.
    Shazly GA.
    Biomed Res Int; 2017 Aug 25; 2017():2120734. PubMed ID: 28194408
    [Abstract] [Full Text] [Related]

  • 23. Sustained delivery and expression of plasmid DNA based on biodegradable polyester, poly(D,L-lactide-co-4-hydroxy-L-proline).
    Li Z, Huang L.
    J Control Release; 2004 Aug 27; 98(3):437-46. PubMed ID: 15312999
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of implant diameter, drug loading and end-capping on praziquantel release from PCL implants.
    Li C, Cheng L, Zhang Y, Guo S, Wu W.
    Int J Pharm; 2010 Feb 15; 386(1-2):23-9. PubMed ID: 19895876
    [Abstract] [Full Text] [Related]

  • 26. Dual effect biodegradable ciprofloxacin loaded implantable matrices for osteomyelitis: controlled release and osteointegration.
    Hanafy AF, Ali HSM, El Achy SN, Habib EE.
    Drug Dev Ind Pharm; 2018 Jun 15; 44(6):1023-1033. PubMed ID: 29484904
    [Abstract] [Full Text] [Related]

  • 27. Development of intra-vaginal matrices from polycaprolactone for sustained release of antimicrobial agents.
    Dang NT, Turner MS, Coombes AG.
    J Biomater Appl; 2013 Jul 15; 28(1):74-83. PubMed ID: 22684517
    [Abstract] [Full Text] [Related]

  • 28. Designing bioresorbable polyester matrices for controlled doxorubicin release in glioma therapy.
    Kasperczyk J, Stoklosa K, Dobrzynski P, Stepien K, Kaczmarczyk B, Dzierzega-Lecznar A.
    Int J Pharm; 2009 Dec 01; 382(1-2):124-9. PubMed ID: 19715746
    [Abstract] [Full Text] [Related]

  • 29. Biodegradable polymers in controlled drug delivery.
    Heller J.
    Crit Rev Ther Drug Carrier Syst; 1984 Dec 01; 1(1):39-90. PubMed ID: 6400195
    [Abstract] [Full Text] [Related]

  • 30. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
    Packhaeuser CB, Kissel T.
    J Control Release; 2007 Nov 06; 123(2):131-40. PubMed ID: 17854938
    [Abstract] [Full Text] [Related]

  • 31. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.
    Al-Kassas RS, El-Khatib MM.
    Drug Deliv; 2009 Apr 06; 16(3):145-52. PubMed ID: 19514974
    [Abstract] [Full Text] [Related]

  • 32. In vitro and in vivo testing of bioabsorbable antibiotic containing bone filler for osteomyelitis treatment.
    Koort JK, Suokas E, Veiranto M, Mäkinen TJ, Jalava J, Törmälä P, Aro HT.
    J Biomed Mater Res A; 2006 Sep 01; 78(3):532-40. PubMed ID: 16736479
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.
    Ong HX, Benaouda F, Traini D, Cipolla D, Gonda I, Bebawy M, Forbes B, Young PM.
    Eur J Pharm Biopharm; 2014 Jan 01; 86(1):83-9. PubMed ID: 23851077
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Preparation of Tacrolimus loaded micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone).
    Wang Y, Wang C, Fu S, Liu Q, Dou D, Lv H, Fan M, Guo G, Luo F, Qian Z.
    Int J Pharm; 2011 Apr 04; 407(1-2):184-9. PubMed ID: 21251958
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Novel biopolymers as implant matrix for the delivery of ciprofloxacin: biocompatibility, degradation, and in vitro antibiotic release.
    Fulzele SV, Satturwar PM, Dorle AK.
    J Pharm Sci; 2007 Jan 04; 96(1):132-44. PubMed ID: 16960824
    [Abstract] [Full Text] [Related]

  • 39. Poly(lactide-co-glycolide) microparticles as systems for controlled release of proteins -- preparation and characterization.
    Porjazoska A, Goracinova K, Mladenovska K, Glavas M, Simonovska M, Janjević EI, Cvetkovska M.
    Acta Pharm; 2004 Sep 04; 54(3):215-29. PubMed ID: 15610618
    [Abstract] [Full Text] [Related]

  • 40. Liposome combined porous beta-TCP scaffold: preparation, characterization, and anti-biofilm activity.
    Zhu CT, Xu YQ, Shi J, Li J, Ding J.
    Drug Deliv; 2010 Aug 04; 17(6):391-8. PubMed ID: 20429845
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.